These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22960407)

  • 21. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Pachuta A; Bochenski M; Silberring J
    Peptides; 2009 Jun; 30(6):1165-72. PubMed ID: 19463751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF).
    Huang EY; Li JY; Tan PP; Wong CH; Chen JC
    Peptides; 2000 Feb; 21(2):205-10. PubMed ID: 10764946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analgesic activity of morphiceptin, beta-casomorphin-4, and deltakephalin in normotensive Wistar-Glaxo and spontaneously hypertensive rats.
    Widy-Tyszkiewicz E; Członkowski A
    Peptides; 1989; 10(3):539-44. PubMed ID: 2780414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist.
    Fang Q; Guo J; He F; Peng YL; Chang M; Wang R
    Peptides; 2006 Sep; 27(9):2207-13. PubMed ID: 16762456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents.
    Elhabazi K; Humbert JP; Bertin I; Quillet R; Utard V; Schneider S; Schmitt M; Bourguignon JJ; Laboureyras E; Ben Boujema M; Simonnet G; Ancel C; Simonneaux V; Beltramo M; Bucher B; Sorg T; Meziane H; Schneider E; Petit-Demoulière B; Ilien B; Bihel F; Simonin F
    Neuropharmacology; 2017 May; 118():188-198. PubMed ID: 28288815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids.
    Yaksh TL; Malmberg AB; Ro S; Schiller P; Goodman M
    J Pharmacol Exp Ther; 1995 Oct; 275(1):63-72. PubMed ID: 7562596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of novel peripherally active morphiceptin analogs.
    Gach K; do-Rego JC; Fichna J; Storr M; Delbro D; Toth G; Janecka A
    Peptides; 2010 Aug; 31(8):1617-24. PubMed ID: 20434497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide FF and related peptides attenuates warm-, but not cold-water swim stress-induced analgesia in mice.
    Li N; Han ZL; Fang Q; Wang ZL; Tang HZ; Ren H; Wang R
    Behav Brain Res; 2012 Aug; 233(2):428-33. PubMed ID: 22659392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dansyl-PQRamide, a possible neuropeptide FF receptor antagonist, induces conditioned place preference.
    Huang EY; Li JY; Wong CH; Tan PP; Chen JC
    Peptides; 2002 Mar; 23(3):489-96. PubMed ID: 11835998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NPYFa, A Chimeric Peptide of Met-Enkephalin, and NPFF Induces Tolerance-Free Analgesia.
    Mudgal A; Kumar K; Mollereau C; Pasha S
    Chem Biol Drug Des; 2016 Jun; 87(6):885-94. PubMed ID: 26802437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs.
    Fichna J; do-Rego JC; Costentin J; Chung NN; Schiller PW; Kosson P; Janecka A
    Biochem Biophys Res Commun; 2004 Jul; 320(2):531-6. PubMed ID: 15219861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice.
    Fu CY; Zhao YL; Dong L; Chen Q; Ni JM; Wang R
    Brain Behav Immun; 2008 Aug; 22(6):850-60. PubMed ID: 18262387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cerebral ventricles perfusion with morphiceptin and Met-enkephalin on trigemino-hypoglossal reflex in rats.
    Zubrzycka M; Fichna J; Janecka A
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 2):741-50. PubMed ID: 12510860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynorphin: potent analgesic effect in spinal cord of the rat.
    Han JS; Xie CW
    Sci Sin B; 1984 Feb; 27(2):169-77. PubMed ID: 6147015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropeptide FF receptors exert contractile activity via inhibition of nitric oxide release in the mouse distal colon.
    Fang Q; Guo J; Chang M; Chen LX; Chen Q; Wang R
    Peptides; 2005 May; 26(5):791-7. PubMed ID: 15808909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
    Shook JE; Pelton JT; Lemcke PK; Porreca F; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.